COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
InSilixa develops CMOS-integrated molecular diagnostic biochips and point-of-care systems for disposable, high-parallelism, multiplexed genomic tests for rapid pathogen identification and antibiotic-resistance detection, using university-licensed semiconductor IP.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors